Trinidad and Tobago · Delayed Price · Currency is TTD Medcorp Statistics
Total Valuation
Medcorp has a market cap or net worth of TTD 254.47 million. The enterprise value is 316.34 million.
| Market Cap | 254.47M |
| Enterprise Value | 316.34M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Sep 14, 2026 |
Share Statistics
Medcorp has 7.83 million shares outstanding. The number of shares has increased by 4.34% in one year.
| Current Share Class | 7.83M |
| Shares Outstanding | 7.83M |
| Shares Change (YoY) | +4.34% |
| Shares Change (QoQ) | +4.35% |
| Owned by Insiders (%) | 82.96% |
| Owned by Institutions (%) | n/a |
| Float | 1.33M |
Valuation Ratios
The trailing PE ratio is 14.03.
| PE Ratio | 14.03 |
| Forward PE | n/a |
| PS Ratio | 2.05 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | 10.96 |
| P/OCF Ratio | 10.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.52, with an EV/FCF ratio of 13.62.
| EV / Earnings | 17.46 |
| EV / Sales | 2.55 |
| EV / EBITDA | 8.52 |
| EV / EBIT | 15.16 |
| EV / FCF | 13.62 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.83.
| Current Ratio | 2.48 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 2.54 |
| Debt / FCF | 3.75 |
| Interest Coverage | 4.80 |
Financial Efficiency
Return on equity (ROE) is 18.72% and return on invested capital (ROIC) is 10.87%.
| Return on Equity (ROE) | 18.72% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 10.87% |
| Return on Capital Employed (ROCE) | 9.68% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 123.89M |
| Profits Per Employee | 18.12M |
| Employee Count | 1 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 9.21 |
Taxes
| Income Tax | -1.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.67% |
| 50-Day Moving Average | 39.98 |
| 200-Day Moving Average | 44.04 |
| Relative Strength Index (RSI) | 4.30 |
| Average Volume (20 Days) | 20 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medcorp had revenue of TTD 123.89 million and earned 18.12 million in profits. Earnings per share was 2.32.
| Revenue | 123.89M |
| Gross Profit | 59.11M |
| Operating Income | 18.04M |
| Pretax Income | 17.11M |
| Net Income | 18.12M |
| EBITDA | 22.82M |
| EBIT | 18.04M |
| Earnings Per Share (EPS) | 2.32 |
Balance Sheet
The company has 25.15 million in cash and 87.01 million in debt, with a net cash position of -61.86 million or -7.90 per share.
| Cash & Cash Equivalents | 25.15M |
| Total Debt | 87.01M |
| Net Cash | -61.86M |
| Net Cash Per Share | -7.90 |
| Equity (Book Value) | 105.24M |
| Book Value Per Share | 13.16 |
| Working Capital | 37.10M |
Cash Flow
In the last 12 months, operating cash flow was 24.75 million and capital expenditures -1.53 million, giving a free cash flow of 23.22 million.
| Operating Cash Flow | 24.75M |
| Capital Expenditures | -1.53M |
| Depreciation & Amortization | 4.78M |
| Net Borrowing | -17.21M |
| Free Cash Flow | 23.22M |
| FCF Per Share | 2.97 |
Margins
Gross margin is 47.71%, with operating and profit margins of 14.56% and 14.63%.
| Gross Margin | 47.71% |
| Operating Margin | 14.56% |
| Pretax Margin | 13.81% |
| Profit Margin | 14.63% |
| EBITDA Margin | 18.42% |
| EBIT Margin | 14.56% |
| FCF Margin | 18.74% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 6.15%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 6.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 86.42% |
| Buyback Yield | -4.34% |
| Shareholder Yield | 1.81% |
| Earnings Yield | 7.12% |
| FCF Yield | 9.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medcorp has an Altman Z-Score of 3.71 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.71 |
| Piotroski F-Score | 6 |